Darunavir Tablet
Product Images NDC 76282-738

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Darunavir (NDC 76282-738). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (4afcb3c7 F5a1 4c46 9955 970ad02fdecb 01)

Image (4afcb3c7 F5a1 4c46 9955 970ad02fdecb 01)
Chemical structure of darunavir, showing the molecular components including a sulfonamide group, phenyl ring, and multiple oxygen and nitrogen atoms, with the formula also indicating 2.5 molecules of water (2.5 H2O) associated.*
FDA Label Image

Bottle Label 600 mg Exelan (Bottle Label 600mg Exelan)

Bottle Label 600 mg Exelan (Bottle Label 600mg Exelan)
Darunavir Tablets 600 mg oral tablet label from Exelan Pharmaceuticals Inc. The label includes an NDC number, a warning alert about medicines not to be taken with Darunavir Tablets, storage instructions, and manufacturer details. The package contains 60 tablets and is labeled Rx only.*
FDA Label Image

Bottle Label 800 mg Exelan (Bottle Label 800mg Exelan)

Bottle Label 800 mg Exelan (Bottle Label 800mg Exelan)
Darunavir Tablets 800 mg film-coated oral tablets in a 30-count bottle label by Exelan Pharmaceuticals Inc. The label includes storage instructions, a warning about medicines that should not be taken with Darunavir, and manufacturer details including InvaGen Pharmaceuticals, Inc. and Exelan Pharmaceuticals, Inc.*
FDA Label Image

Pk Results (Fig 02)

Pk Results (Fig 02)
A chart presenting geometric mean ratios (GMR) with 90% confidence intervals for pharmacokinetic parameters (AUC, Cmin) of darunavir/ritonavir administered twice daily and once daily during the second and third trimesters of pregnancy compared to postpartum values. The x-axis shows GMR values ranging from 0.0 to 2.5, with data points and error bars for total and unbound drug concentrations.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.